Draken Pharmaceutical Private Limited
About Draken Pharmaceutical Private Limited
Data last updated:
Draken Pharmaceutical Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 February 2017.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC313545.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Shilpi Gupta and Mansi Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Plot No. 6 First Floor Park End Vikas Marg, Delhi, India – 110092.
Company details
Contact details
Draken Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 6 First Floor Park End Vikas Marg, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Draken Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Draken Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Draken Pharmaceutical Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Draken Pharmaceutical Private Limited, buy the company report.
Board of directors of Draken Pharmaceutical Private Limited
Draken Pharmaceutical has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shilpi Gupta | Director | 07 Nov 2022 | 3 Years 11 Months | As last reported |
| Mansi Aggarwal Also directs: Little Tinkers to Little Thinkers Educational LLP, CP Storage Studio LLP, A1 Plus Edugro LLP and 5 more | Director | 02 Oct 2018 | 8 Years 0 Months | As last reported |
Auditor
Draken Pharmaceutical Private Limited is audited by RAJENDRA PRASAD & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJENDRA PRASAD & ASSOCIATES | FY 2018 | 020817N |
Shareholding
The shareholding of Draken Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Draken Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Draken Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Draken Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Draken Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Draken Pharmaceutical Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Chhavi Gupta ceased to be Director on 09 Nov 2022.
Frequently asked questions
Draken Pharmaceutical has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Draken Pharmaceutical was a private limited company based in Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 27 February 2017 and is registered under CIN U51909DL2017PTC313545. The company has been struck off by the Registrar of Companies and is no longer operational.
Draken Pharmaceutical had 2 directors:
- Shilpi Gupta - Director
- Mansi Aggarwal - Director
The CIN (Corporate Identification Number) of Draken Pharmaceutical is U51909DL2017PTC313545. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Draken Pharmaceutical is at Plot No. 6 First Floor Park End Vikas Marg, Delhi, India – 110092.
Draken Pharmaceutical was incorporated on 27 February 2017. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Draken Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
Draken Pharmaceutical operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Chhavi Gupta ceased to be Director on 09 Nov 2022. Shilpi Gupta was appointed as Director on 07 Nov 2022. Mansi Aggarwal ceased to be Additional Director on 21 Sep 2019. Draken Pharmaceutical has 6 board changes on record in total.
The compliance status of Draken Pharmaceutical is compliant as of 16 September 2026.